Two top healthcare awards underline Brainomix's landmark achievements in 2024 and the validation of its software's impact on treatment rates
Eskisehir Osmangazi University Hospital (EOUH), recently integrated Brainomix 360 Stroke software into their stroke care pathway. The hospital team anticipates advancements in patient selection for treatment, aided by the software’s cutting-edge imaging and analysis capabilities.
Brainomix 360 Stroke has been deployed nation-wide to all stroke centers across Wales, helping improve stroke treatment rates across this country of 3 million. In the last year, the thrombectomy rates have increased by more than 44%, expanding this life-changing treatment to more patients.
In 2022 Brainomix were awarded a world-first, nationwide tender for its Brainomix 360 Stroke platform in Hungary. The software is now deployed across 28 sites and has processed more than 36,000 scans, with the total number of thrombectomies in Hungary now up more than 50%.
Shawn Theoff, a retired postman from Canterbury, suffered a stroke several years ago. He says that because of his quick AI-enhanced treatment with Brainomix 360 Stroke he was was out walking again within weeks.
Dr David Hargroves highlights the clinical value that tools like Brainomix 360 Stroke are delivering for stroke patients.
Riaz Rahman, Sales Director, EMEA, reflects on his 8 years with Brainomix, a period of time that has seen broad adoption of stroke AI imaging and transformative growth for the Oxford-based AI pioneer, whose Brainomix 360 system has processed more than 2-million scans globally.
Dr. Ingrid Kane, a stroke physician at UHSussex discusses the added flexibility she sees using the Brainomix Mobile App
Dr. Ondrej Volny, neurologist and vice-chair for research at UHO shares insights into the impact of Brainomix 360 on patient outcomes, clinical workflows, and the challenges faced during integration.
Nisha Patel is a 31-year-old new mother who recently suffered a stroke, but thanks to a new initiative that involved the deployment of Brainomix 360 Stroke across all hospitals in Wales, she was quickly diagnosed and promptly treated, enabling her to make a full recovery.
New data presented at Society of NeuroInterventional Surgery (SNIS) Annual Meeting in Colorado Spring highlights the cutting-edge, AI-enabled technology that has been developed for the Brainomix 360 Stroke platform
The project will evaluate the real-world impact of Brainomix's e-Lung imaging software to improve the identification and access to treatment for people with progressive pulmonary fibrosis in the US
The integration of Brainomix 360 at OUH, guided by the expertise of the entire staff, represents a paradigm shift in stroke care. Through enhanced efficiency, collaboration, and patient-centric decision-making, Brainomix works as a catalyst for transformative change in stroke management. Overall working to help physicians achieve the goal of ‘No LVO Left Behind.’
A new series of studies were unveiled, highlighting the prognostic value of Brainomix lung imaging biomarkers in patients with fibrotic lung disease.
Established market leader in stroke AI imaging receives its first FDA clearance in the lung imaging space. With this expanded foundation of AI-driven healthcare solutions, the Oxford-based company remains committed to driving innovation and delivering impactful advancements in imaging biomarkers.
With these latest studies, the firmly established European market leader in stroke AI imaging adds to its growing body of evidence. The latest research reflects the company's extensive academic collaborations and its growing Life Science partnerships.
The largest real-world evaluation of stroke AI imaging, involving more than 80,000 patients at 26 sites over a 3-year period, showed Brainomix 360 Stroke was associated with an additional 50% increase in the number of patients receiving mechanical thrombectomy, while also improving the speed of treatment by 49 minutes.
We are inspired by stroke survivors like Jess Tierney, who suffered a stroke at age 29 and is now fully focused on her rehabilitation and channeling her energies towards raising awareness around stroke. Learn more about her story and her courageous spirit.
Brainomix and AstraZeneca partnered to analyze the Phase 2 tralokinumab clinical trial data of Idiopathic Pulmonary Fibrosis (IPF) patients, leveraging Brainomix's AI-powered e-Lung software and biomarkers to uncover novel insights. Published data shows e-Lung could play a role in stratifying patients in clinical trials most at risk of decline, outperforming current standard measures.
The Economist cited Brainomix 360 Stroke as an example of an AI technology making an impact on healthcare, helping more stroke patients achieve an improved outcome.
Study conducted at UCL Hospital in London adds to the growing body of real-world evidence showcasing the clinical value that e-ASPECTS can deliver to stroke teams.
Professor Erika Denton noted the impact Brainomix 360 Stroke can deliver by "significantly reducing the pathway of care for people presenting with stroke symptoms, with a profound impact in terms of morbidity and mortality from stroke.”
Study demonstrates the value of our unique e-Lung biomarkers to accurately predict IPF patients at risk of future lung function decline, a prognostic capability which can benefit future clinical trials.
A newly published study in Frontiers demonstrates the impact of the Brainomix 360 Stroke platform, trebling the number of stroke patients achieving a better outcome.
The University of Oxford recently featured an article on Brainomix, highlighting the transformative progress we are achieving in stroke care. Our Oxford heritage continues to drive our focus on scientific excellence and world-class innovation.
Our CEO Michalis Papadakis was recently interviewed by Helen Albert for her review of how AI is leading the way to more precise diagnostics and disease risk prediction.
New guidance from NICE, the globally respected health assessor, endorses the use of Brainomix 360 Stroke, acknowledging the impact that the AI-enabled software has demonstrated on stroke care, expanding patient access to life-changing treatments. Brainomix was one of only two companies granted this highly coveted endorsement.
From the pioneers of simple imaging solutions, this latest innovation to the Brainomix 360 stroke platform can generate critical information from universally available non-contrast CT scans, alerting clinicians of suspected large vessel occlusions (LVO) and intracranial hemorrhages (ICH), supporting treatment and transfer decisions.
Brainomix were recognized "for the clear evidence of their effectiveness and delivering on an area of significant unmet need."
Launched at the Society of Vascular and Interventional Neurology (SVIN) Conference in Miami, the Brainomix 360 platform is powered by best-in-class algorithms, delivering a unique technology for both specialist and non-specialist stroke centers that is poised to transform stroke care
“We are convinced that the introduction of Brainomix AI technology will lead to a significant improvement in our ability to manage stroke cases. Our aim is to be a leader in stroke - that is why we want to use the latest advances, to be able to give patients the best possible care."
“This deployment of Brainomix and networked AI across East of England will enable more patients to get the right treatment, in the right place, at the right time, to help save lives and prevent people from severe disability.”
Stroke patients are getting the care they need faster thanks to new cutting-edge computer technology.
Brainomix are showcased as one of the 50 companies in PwC UK’s 'Life Sciences Future 50' report, which spotlights the world-class scientific and innovative contributions of the UK's life sciences sector.
e-Lung featured as part of the BBC coverage of the TIPAL study for lung fibrosis
Brainomix Awarded Innovate UK Grant to Collaborate with Swiss-based Nanoflex Robotics
The article highlights the impact of e-Stroke on a network, enabling faster detection of stroke to allow more patients acces to thrombectomy, resulting in the prevention of stroke-related disability and death.
The company will apply its cutting-edge AI technology to run a sub-study assessing the value of its novel imaging biomarkers
The results generated by Brainomix's core lab analysis with its AI software reinforced glenzocimab's mode of action in stroke patients
Sites with e-Stroke are delivering higher thrombectomy rates for stroke patients in a faster time, according to a recent report from the Oxford Academic Health Science Network
Brainomix was awarded Innovative Tech Company of the Year as well as Life Sciences & Health Tech Company of the Year.
Brainomix's e-Stroke technology featured in the Department of Health's recent showcase of “most promising AI imaging and decision support tools” as part of the roll-out of the £21M AI Diagnostic Fund.
Brainomix’s e-Lung software is powered by unique imaging biomarkers that have demonstrated superior prognostic value compared with traditional measures in both non-IPF and IPF ILD patients.
We've relocated to the landmark Seacourt Tower in Botley
Oxford & Chicago facilities to accommodate growing team of specialists at company focused on treatments for stroke, lung fibrosis and cancer
Oxford-based AI-powered medtech solutions company Brainomix has announced its move to a new head office at the Seacourt Tower in Botley.
Artificial intelligence (AI) software developer Brainomix has expanded into new headquarters in Oxford, U.K.
The e-Stroke platform was nominated in the category of "Best Digital Health Solution," recognizing its transformative impact stroke care.
The Oxford-based company is the first AI imaging company to join the organization
Our stroke AI solutions are now poised to take its transformative technology to US stroke centers
National Consortium of Intelligent Medical Imaging video explaining how our e-Stroke software is reducing door in door out time for stroke patients
The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients
Research will analyse how Huawei’s wearable technology detects atrial fibrillation in post-stroke patients
This major study will look at how effective a wearable device and Brainomix AI software are in the detection of atrial fibrillation
Strategic partnership increases access to advanced AI-assisted stroke care
Brainomix e-Stroke system supporting cut in waiting times and reducing disability
Prof Kevin Moore advocates for the wider adoption of e-Stroke as a way of improving outcomes for stroke patients.
Brainomix featured as part of a 'Rising Stars' piece on fast-growing UK health and life sciences companies, with an interview with CEO and Co-Founder Michalis Papadakis.
Brainomix featured in The Times, highlighting the impact that the e-Stroke platform has had on stroke care in the NHS.
Use of cutting-edge AI technology is associated with a tripling of the number of patients recovering and able to perform daily activities from 16% to 48%.
Brainomix to distribute Pixyl.Neuro.MS Software as a Service (SaaS) solution exclusively in the UK and Ireland, the Nordics and key Eastern Europe markets
Visionable’s digital healthcare collaboration platform, used with Brainomix’s e-Stroke software, will allow more stroke patients to get appropriate treatment.
Benefits of combining Visionable’s virtual platform with Brainomix’s e-Stroke imaging already demonstrated at Ipswich Hospital
A partnership between two UK digital health companies – Brainomix and Visionable – aims to overcome stroke care bottlenecks.
Link up will take on bottlenecks in time-sensitive stroke care pathway across the UK.
Visionable and Brainomix use AI-powered solutions to address time-sensitive stroke care.
Study to evaluate e-ACT for automated assessment of disease progression and treatment response for lung cancer
The partnership will focus on quantitative analysis of imaging data by Brainomix's e-ILD software within the Phase 2 Study of BBT-877 in IPF
Brainomix awarded a world-first, nationwide tender for its e-Stroke platform, which will be deployed across all stroke centers in Hungary as part of the National Institute for Health Development initiative to improve stroke care.
Brainomix and OSIC present new data showcasing the value of its new e-ILD platform, centered around a novel, AI-powered imaging biomarker that has demonstrated superior prognostic value.
AI stroke imaging will be deployed across centers in Hungary after Brainomix was awarded a national tender.
Brainomix claims first national contract – from Hungary – for its AI platform for improved diagnosis and treatment of stroke.
Brainomix software deployed to 10 stroke centers across the region after winning a highly competitive, multi-year EU tender process.
New CFO and CRO appointed with overall resources more than doubling following last December’s £16M financing round
Lecce have seen their thrombectomy service double in two years, on target to achieve more than 140 procedures in 2022.
Euroclinic invests in artificial intelligence, setting the bar higher in the handling and treatment of patients with stroke.
The imaging biomarker has demonstrated superior prognostic value compared with traditional measures, and may provide a more reliable measurement of the effects of novel therapies in clinical trials
The collaboration will focus on the development of AI tools to improve the accuracy and standardization of tumor measurement in lung cancer trials
The latest advancement will extend the e-Stroke platform to enable messaging and image-sharing across stroke networks, helping to optimize workflow and facilitate faster treatment
The Series B investment will enable the Oxford-based company to expand its award-winning artificial intelligence (AI) portfolio into new indications and extend into new high-growth markets
Barts NHS Trust provides a 24/7 thrombectomy service, and is on pace to treat more than 300 patients this year with this life-saving procedure
Brainomix were awarded the first national tender in Europe to deploy its AI stroke software as part of the Polish Ministry of Health initiative to improve stroke care
The AI-powered software has been a real game changer, helping the Trust make faster treatment and transfer decisions for its stroke patients
The roll-out of e-Stroke across Sussex is aimed at expanding access to fast, effective, lifesaving treatment for all stroke patients.
The segment showcases how Brainomix's e-Stroke software is helping the Royal Berkshire Hospital stroke team deliver best-in-class care.
Saving time in delivering thrombectomy services could be the difference between a good outcome and someone facing a life with a serious disability.
This latest deployment of Brainomix’s transformative stroke AI imaging platform will support the Trust’s focus on delivering innovative care for its patients
Brainomix continues to be a strong partner of NHS stroke teams, with this latest deployment part of a wider North East of England stroke AI network
Article highlights the value of e-Stroke in helping physicians identify stroke and optimize treatment
The stroke team at Sana Kliniken Lübeck share their experience with e-Stroke over the past 12 months
Recognized as one of the most innovative companies in Europe, Brainomix is attracting the attention of leading tech investors
The partnership will enable both companies to work towards improving care across stroke networks
Results will enable stroke networks to make more confident treatment decisions in both specialist and non-specialist stroke hospitals
2020 was marked by a global pandemic – but also saw significant progress and innovation
Joins renowned global organization connecting academia, industry and philanthropy in the fight against lung disease
Brainomix software to be featured in a number of scientific presentations and posters
Joins global network of fast-growing, innovative companies founded by Greek entrepreneurs.
We'd like to introduce you to the new Brainomix identity, which reflects our company's world-class expertise and focus on delivering cutting-edge AI solutions for better treatment decisions.
Announcement of New Chairperson and Expanded Board Featured in FT
The Oxford-based company at the forefront of medical AI imaging welcomes new Board members with pharmaceutical and imaging expertise
e-Stroke Suite 10.0 provides first-ever clot detection from non-contrast CT scans, a paradigm shift
Brainomix awarded NHSX grant for AI software
University Hospital Milton Keynes NHS FT has adopted AI technology from Brainomix into its Stroke Practice
Company selected to participate in groundbreaking NHS AI initiative
AI is now helping clinicians at Milton Keynes deliver quicker and safer care to stroke patients
Dr Kiruba Nagaratnam discusses changes to the thrombectomy pathway and assesment during COVID-19
Trust becomes latest hospital in region to adopt software for Thames Valley Stroke Network
e-Stroke Suite was showcased as part of a Sky News segment on how AI solutions are helping stroke teams
An update on some of the exciting developments from the first half of 2020
Deployment of e-Stroke software across the UK continues with Northeast region
Clinicians are making swift, accurate decisions around stroke care thanks to AI-enabled imaging software
Brainomix's new e-Stroke Mobile App provides landmark capabilities for stroke networks
Stroke team using e-Stroke Mobile app to maintain optimal stroke care during pandemic
New software promises to improve stroke service in Lübeck
Article focused on the role of AI solutions in healthcare
e-Stroke Suite has been deployed at Royal Berks
e-Stroke Suite is being rolled out across one of the largest stroke networks in Slovakia
Brainomix software will help stroke network optimize its service
The latest software includes the new e-Stroke Cloud Service to facilitate faster sharing of results across a stroke network
Awards recognize companies with greatest potential to change the way healthcare is delivered
Brainomix CEO and Co-Founder, Dr Michalis Papadakis, discusses the role of AI in healthcare
The collaboration will enable Trusts in the network to introduce intelligent AI algorithms into existing radiology workflows
Results showed that treatment rates for stroke patients improved and treatment times were reduced following the installation of Brainomix’s e-Stroke Suite
e-Stroke Suite increased thrombolysis and thrombectomy treatment rates for stroke patients
Brainomix committed to working with clinicians to make life-saving treatments accessible to all stroke patients
New study shows Brainomix’s unique AI-driven software gives doctors reliable information to treat stroke patients from universally available imaging systems
Brainomix were recently featured in a BBC News Technology segment focused on AI in healthcare
Event focused on NHS Long Term Plan and the role of AI solutions
First trial to demonstrate efficacy of thrombectomy in developing world healthcare system
Brainomix’s e-Stroke Suite was recently featured in an article published by Klinikum Braunschweig
New study shows Brainomix e-CTA provides similar measures to experts and improves inter-rater reliability
Brainomix invites you to join us at ESOC 2019 to experience first-hand the most comprehensive imaging solution
Guidelines reinforce the importance of imaging in determining patient eligibility
e-ASPECTS software supports physicians’ diagnostic skills by delivering fast and consistent stroke diagnosis
Ischemic injury on e-ASPECTS, but not RAPID software, predicted good clinical outcome at 3 months after stroke
Awards recognize excellence in European Radiology
Study suggests it may be reasonable to select patients for thrombectomy in centres without access to advanced imaging using the e-ASPECTS tool in combination with clinical criteria
Brainomix is the sole imaging partner for the community of more than 1,000 hospitals enrolled in the Angels Initiative
Stroke imaging software, e-Stroke Suite, to demonstrate life-saving impact of AI-based technologies
New publication in Stroke journal with 1,500 patients from the ENCHANTED trial database
The new e-Stroke Suite is the complete decision support software for the assessment of CT and MR scans of ischemic stroke patients
e-CTA provides fast, automated collateral assessments powered by AI and big data
Brainomix builds on partnership with Boehringer Ingelheim for AI-assisted fast treatment of stroke victims
New version of Brainomix’s flagship product, e-ASPECTS, offers exciting new features and improvements
Brainomix will be exhibiting at the 14th Congress of the World Federation of Interventional and Therapeutic Neuroradiology
The only mechanical thrombectomy trial in a developing country is currently taking place in Brazil
A new study shows e-ASPECTS correlates with and is a predictor of outcome
" Summertown firm's Brainy idea will help stroke victims across Europe..."
Brainomix will be participating at the 3rd European Stroke Conference (ESOC 2017)
Partnership will enable both companies to help improve stroke care across the region
Brainomix will be attending the Annual Meeting of the German & Austrian Stroke Society
The new software version of Brainomix’s flagship product offers exciting new features and improvements
Results show e-ASPECTS is on average statistically non-inferior to expert neuroradiologists
Funding will enable Brainomix to further commercialize its proprietary software
Will be attending the neuroradiology event in Cologne
Guide provides an overview of CT scanning techniques and their clinical application in ischemic stroke
Study illustrates the potential benefits of e-ASPECTS when integrated within Mobile Stroke Units
Brainomix is attending the 2016 European Stroke Organization Conference in Barcelona
Study shows e-ASPECTS performs as well as stroke experts when assessing brain CT scans of stroke patients
Brainomix is attending this year’s ECR 2016 - European Congress of Radiology in Vienna
Brainomix will be attending the 33rd Annual Meeting of the German Stroke Society
Our patient selection webinar is now available to view online!
Oxford - December 7, 2015 - Brainomix announces a new release for
Oxford, Tuesday 1 December 2015 - Brainomix is attending this year’s UK Stroke Forum
Brainomix is among the companies presented in this year’s prestigious Barclays and
Brainomix will be presenting at Medica 2015 (Hall 16 G25-1) in Dusseldorf
Brainomix was one of 100 companies to be selected to showcase its innovation
Brainomix is one of three companies shortlisted in the Oxford category of
Brainomix Limited, a developer of automated medical imaging software for neurological
The first clinical installations of the e-ASPECTS automated CT scan scoring software
Breakthrough technology automates analysis of CT brain scans to support doctors in
Brainomix is exhibiting at the World Stroke Congress 2014 in Istanbul
Novotel London West - 13 May 2014 15:50. Michalis Papadakis, CEO of
With the continuing expansion of the Brainomix team, the company has moved
Brainomix, a start-up from Isis Innovation the Oxford University Technology Transfer Company
The latest Oxford spin-out puts the expertise of a stroke assessment team